Aprepitant for Patients Receiving Highly Emetogenic Chemotherapy: An Economic Analysis for Singapore

Authors:

Abstract
No abstract available
Funding Information
  • Merck Sharp & Dohme

This publication has 16 references indexed in Scilit: